Strongbridge Biopharma PLC Net Profit Margin 2016-2021 | SBBP
Strongbridge Biopharma PLC net profit margin from 2016 to 2021. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2021-06-30 | $0.03B | $-0.04B | -117.65% |
| 2021-03-31 | $0.03B | $-0.04B | -137.50% |
| 2020-12-31 | $0.03B | $-0.05B | -145.16% |
| 2020-09-30 | $0.03B | $-0.04B | -144.83% |
| 2020-06-30 | $0.03B | $-0.05B | -196.30% |
| 2020-03-31 | $0.03B | $-0.04B | -176.00% |
| 2019-12-31 | $0.02B | $-0.05B | -222.73% |
| 2019-09-30 | $0.02B | $0.04B | 209.52% |
| 2019-06-30 | $0.02B | $0.04B | 185.00% |
| 2019-03-31 | $0.02B | $0.04B | 233.33% |
| 2018-12-31 | $0.02B | $0.03B | 172.22% |
| 2018-09-30 | $0.02B | $-0.07B | -450.00% |
| 2018-06-30 | $0.01B | $-0.09B | -614.29% |
| 2018-03-31 | $0.01B | $-0.11B | -941.67% |
